for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Deals

Roche Holding to buy TIB Molbiol to enhance molecular diagnostics

FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann

ZURICH (Reuters) - Roche Holding has agreed to buy long-term partner TIB Molbiol, a German biotech group, to enhance its portfolio of molecular diagnostics, the Swiss drugmaker said on Thursday, giving no financial terms for a deal set to close by year-end.

The acquisition will provide a wide range of assays forinfectious diseases, such as the identification of SARS-CoV-2 variants.

TIB Molbiol's portfolio of more than 45 CE-IVD assays and more than 100 research use assays is already available on Roche's LightCycler PCR systems and MagNA Pure sample preparation systems, it said here in a statement.

Reporting by Michael Shields; Editing by Clarence Fernandez

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up